Baxter International Inc. (BAX)
NYSE: BAX · Real-Time Price · USD
24.22
+1.22 (5.30%)
At close: Nov 2, 2026, 4:00 PM EST
24.00
-0.22 (-0.91%)
After-hours: Nov 2, 2026, 4:17 PM EST
Baxter International Financials Overview
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 11,611 | 11,244 | 10,636 | 10,360 | 10,057 | 12,146 |
Revenue Growth | 5.33% | 5.72% | 2.66% | 3.01% | -17.20% | 4.05% |
Gross Profit Gross Profit Growth | 3,875 | 4,018 | 4,210 | 4,180 | 4,165 | 4,865 |
Operating Income Operating Income Growth | 878 | 1,037 | 888 | 896 | 908 | 1,730 |
Net Income Net Income Growth | -723 | -957 | -649 | 2,656 | -2,433 | 1,284 |
Earnings Per Share EPS Growth | -1.40 | -1.87 | -1.27 | 5.25 | -4.83 | 2.53 |
EPS Growth | - | - | - | - | - | 18.58% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Infusion Therapies & Platforms Infusion Therapies & Platforms Growth | 6,181 | 4,101 | 4,103 | 3,960 | 3,817 | 3,844 |
Advanced Surgery Advanced Surgery Growth | 1,305 | 1,198 | 1,104 | 1,051 | 998 | 977 |
Care & Connectivity Solutions Care & Connectivity Solutions Growth | 1,972 | 1,911 | 1,814 | 1,800 | 1,791 | 142 |
Front Line Care Front Line Care Growth | 1,167 | 1,160 | 1,137 | 1,213 | 1,148 | 70 |
Injectables and Anesthesia Injectables and Anesthesia Growth | - | 1,352 | 1,373 | 1,347 | 1,305 | 1,390 |
Drug Compounding Drug Compounding Growth | - | 1,141 | 1,038 | 902 | 821 | 901 |
Other Other Growth | 318 | 381 | 67 | 87 | 177 | 140 |
Revenue (Total) Revenue (Total) Growth | 11,611 | 11,244 | 10,636 | 10,360 | 10,057 | 12,146 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,975 | 1,966 | 1,764 | 3,078 | 1,718 | 2,951 |
Total Debt Total Debt Growth | 8,807 | 9,780 | 13,449 | 14,113 | 17,203 | 18,310 |
Net Cash (Debt) Net Cash Growth | -6,832 | -7,814 | -11,685 | -11,035 | -15,485 | -15,359 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -13.26 | -15.23 | -22.91 | -21.72 | -30.72 | -30.23 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 1,640 | 845 | 1,019 | 1,726 | 1,211 | 2,222 |
Capital Expenditures CapEx Growth | -503 | -513 | -446 | -432 | -377 | -691 |
Free Cash Flow Free Cash Flow Growth | 1,137 | 332 | 573 | 1,294 | 834 | 1,531 |
Free Cash Flow Growth | 365.98% | -42.06% | -55.72% | 55.16% | -45.53% | 32.10% |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 33.37% | 35.73% | 39.58% | 40.35% | 41.41% | 40.05% |
Operating Margin | 7.56% | 9.22% | 8.35% | 8.65% | 9.03% | 14.24% |
Pretax Margin | -1.61% | -4.49% | -2.72% | 2.34% | -32.30% | 9.19% |
Profit Margin | -6.23% | -8.51% | -6.10% | 25.64% | -24.19% | 10.57% |
FCF Margin | 9.79% | 2.95% | 5.39% | 12.49% | 8.29% | 12.61% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 0.040 | 0.520 | 1.040 | 1.160 | 1.150 | 1.085 |
Dividend Per Share Growth | -92.31% | -50.00% | -10.35% | 0.87% | 5.99% | 13.61% |
Dividend Yield | 0.17% | 2.72% | 3.57% | 3.00% | 2.26% | 1.27% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 7.38 | - | 33.47 |
Forward PE | 11.70 | 8.68 | 12.71 | 12.91 | 14.37 | 20.19 |
P/FCF Ratio | 10.86 | 29.59 | 25.98 | 15.16 | 30.81 | 28.07 |
PS Ratio | 1.06 | 0.87 | 1.40 | 1.89 | 2.56 | 3.54 |